Nothing hugely new in the announcement due to the security situation in Israel making it impossible to treat any more patients, but it is worth emphasising that the trial was successful in meeting its primary endpoint. In a disease as terrible as AML any success should be cherished.
Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-11
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.000(0.00%) |
Mkt cap ! $259.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2389 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 300 | 1 |
View Market Depth
| Last trade - 09.56am 12/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |
Day chart unavailable